Effective treatment of recurrent acromegaly with a long-active somatostatin analogue (sandostatin).
作者信息
Miranda R, Zárate A, Ruíz Velasco G
出版信息
Arch Invest Med (Mex). 1988 Oct-Dec;19(4):445-8.
PMID:3245759
Abstract
摘要
相似文献
1
Effective treatment of recurrent acromegaly with a long-active somatostatin analogue (sandostatin).
Arch Invest Med (Mex). 1988 Oct-Dec;19(4):445-8.
2
[Current alternative in the pharmacotherapy of acromegaly: the long-acting somatostatin analogue octreotide].
Orv Hetil. 2002 May 12;143(19 Suppl):1062-6.
3
Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
Acta Neurochir (Wien). 2005 May;147(5):485-93; discussion 493. doi: 10.1007/s00701-005-0511-9. Epub 2005 Apr 4.
4
[Acromegaly associated with McCune-Albright syndrome].
Orv Hetil. 2002 May 12;143(19 Suppl):1070-3.
5
[Experience in treating acromegalic patients with long-acting octreotide].
Orv Hetil. 2002 May 12;143(19 Suppl):1066-70.
6
Octreotide in the management of active acromegaly due to inoperable growth hormone-secreting adenoma.
Recenti Prog Med. 1994 Jan;85(1):13-9.
7
Acromegaly and its treatment.
J Endocrinol. 1997 Oct;155 Suppl 1:S49-51; discussion S67-71.
8
Effect of long-term treatment with somatostatin analogue (SMS 201-995) on pituitary tumor shrinkage in acromegaly--report of two cases.
Neurol Med Chir (Tokyo). 1992 Apr;32(4):215-9. doi: 10.2176/nmc.32.215.
9
Evidence for dopamine agonists in the treatment of acromegaly.
J Endocrinol. 1997 Oct;155 Suppl 1:S59-60.
10
Advances in the medical and surgical treatment of pituitary adenomas: the role of long-acting somatostatin analogs. Participants of the "Conference on Medical and Surgical Treatment of Pituitary Adenomas" (Zürich, 5th October, 1991).
J Endocrinol Invest. 1993 Jun;16(6):449-60. doi: 10.1007/BF03348882.
Zotero 插件